We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Baxter 483 Notes Hold, Investigation Problems
Baxter 483 Notes Hold, Investigation Problems
December 7, 2010
Baxter Pharmaceuticals Solutions was handed a Form 483 when FDA investigators found investigation failures after it used a syringe lot that was on quality assurance hold during filling activities.